knowledge -WSS

knowledge

author：fashion 2025-10-02 22:15:33 - browse：36

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Why are Kaiser Permanente staff considering a strike?

hotspot

WSS

What the cancer research community can learn from the Covid response

Why are Kaiser Permanente staff considering a strike?

Drug for rare kidney disease narrowly misses mark in clinical trial

Stem cell clinics for heart failure: buyer be wary

Senate HELP committee spars over health care workforce policies

Drug for rare kidney disease narrowly misses mark in clinical trial

explore

knowledge

focus

Psychedelics group wrestles with new pharma identity

Lasker Awards 2023: Winners in biomedical research

Virginia high school admissions case could be legal follow

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Peter Hotez and the public health issue of online harassment

Drug for rare kidney disease narrowly misses mark in clinical trial

Jerome Adams on the need for new antivirals for Covid

It's been 20 years since Dolly the sheep. Where's my clone?

Continuity nursing helped my family in our darkest PICU moments

Emergency workers more likely to restrain Black patients: study

explore

Senate HELP committee spars over health care workforce policies

CDC's new outbreak response network to include Northeastern

Lasker Awards 2023: Winners in biomedical research

Ukraine and a new approach to mental health in war

Microbiome research is starting to find links to chronic diseases

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

focus

hotspot

entertainment

explore